Bridgefront Capital’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.02M | Buy |
+22,089
| New | +$1.02M | 0.27% | 92 |
|
|
2024
Q4 | – | Sell |
-21,836
| Closed | -$1.13M | – | 593 |
|
|
2024
Q3 | $1.13M | Sell |
21,836
-592
| -3% | -$30.6K | 0.44% | 37 |
|
|
2024
Q2 | $931K | Buy |
+22,428
| New | +$931K | 0.39% | 57 |
|
|
2024
Q1 | – | Sell |
-5,215
| Closed | -$268K | – | 387 |
|
|
2023
Q4 | $268K | Sell |
5,215
-1,972
| -27% | -$101K | 0.2% | 199 |
|
|
2023
Q3 | $417K | Sell |
7,187
-13,747
| -66% | -$798K | 0.29% | 112 |
|
|
2023
Q2 | $1.34M | Buy |
+20,934
| New | +$1.34M | 0.72% | 7 |
|
|
2023
Q1 | – | Sell |
-7,589
| Closed | -$546K | – | 425 |
|
|
2022
Q4 | $546K | Buy |
+7,589
| New | +$546K | 0.38% | 78 |
|
|
2022
Q1 | – | Sell |
-4,599
| Closed | -$287K | – | 281 |
|
|
2021
Q4 | $287K | Buy |
+4,599
| New | +$287K | 0.28% | 153 |
|
|
2021
Q3 | – | Sell |
-16,186
| Closed | -$1.08M | – | 356 |
|
|
2021
Q2 | $1.08M | Buy |
16,186
+9,603
| +146% | +$642K | 0.41% | 39 |
|
|
2021
Q1 | $416K | Sell |
6,583
-6,907
| -51% | -$436K | 0.13% | 307 |
|
|
2020
Q4 | $837K | Buy |
+13,490
| New | +$837K | 0.29% | 87 |
|